On-Demand Webinars

ABA SUPRATHEL® Expert Panel 2021
“SUPRATHEL® – A new standard in burn care?”

Compendio Médico SUPRATHEL®

Ponente: Dr. Ariel Miranda Altamirano

Compendio Médico SUPRATHEL®

“El amor por los niños ha llevado al doctor Ariel Miranda Altamirano a conformar uno de los espacios más reconocidos del OPD Hospital Civil de Guadalajara y uno de los mejores de América Latina.
Cirujano de profesión, levantó de cero la Unidad de Niños con Quemaduras, del Hospital Civil de Guadalajara “Dr. Juan I. Menchaca”, que ha atendido a miles de pacientes de Jalisco y el occidente de México, no sólo para darles una mejor calidad de vida sino también para darles una esperanza de supervivencia”
Gaceta, por Mariana González Márquez, – marzo 18, 2020

A Potent Versatile Dressing and Skin Substitute – Not Just for Partial Thickness Burns and Donor Sites

https://vimeo.com/522298650

Speaker: Dr. Herbert Haller
Senior Medical Consultant
at Herbert Haller Medical Consulting

A Potent Versatile Dressing and Skin Substitute – Not Just for Partial Thickness Burns and Donor Sites

Dr. Haller will provide an overview of the Suprathel technology, its indications and publications. With more than 15 years of Suprathel experience Dr. Haller is one of the most experienced Suprathel users in the world. He is excited to share his insights into the technology with his colleagues from around the world.

As Xenograft retires, SUPRATHEL® is an important known alternative with excellent outcomes

Speaker: Dr. Roselle Crombie
Widely recognized US General Surgeon who specializes in Burn Surgery practicing at Bridgeport and Yale

As Xenograft retires, SUPRATHEL® is an important known alternative with excellent outcomes

Dr. Crombie is a widely recognized US burn surgeon practicing at Bridgeport and Yale. After years of experience with xenografts, Dr. Crombie replaced the technology with SUPRATHEL two years ago. In this webinar, Dr. Crombie will share her rationale for having transitioned to SUPRATHEL and her experiences with SUPRATHEL compared to xenografts.